Literature DB >> 35284521

Finding a role for cancer vaccines in pancreatic cancer: a model of resilience.

Gentry King1,2, Steven Green1, E Gabriela Chiorean1,2.   

Abstract

Entities:  

Year:  2022        PMID： 35284521      PMCID： PMC8847880          DOI： 10.21037/hbsn-2021-26

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  11 in total

1.  Addition of algenpantucel-L immunotherapy to standard adjuvant therapy for pancreatic cancer: a phase 2 study.

Authors:  Jeffrey M Hardacre; Mary Mulcahy; William Small; Mark Talamonti; Jennifer Obel; Smitha Krishnamurthi; Caio S Rocha-Lima; Howard Safran; Heinz-Joseph Lenz; E Gabriela Chiorean
Journal:  J Gastrointest Surg       Date:  2012-11-15       Impact factor: 3.452

2.  Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline.

Authors:  Edward P Balaban; Pamela B Mangu; Alok A Khorana; Manish A Shah; Somnath Mukherjee; Christopher H Crane; Milind M Javle; Jennifer R Eads; Peter Allen; Andrew H Ko; Anitra Engebretson; Joseph M Herman; John H Strickler; Al B Benson; Susan Urba; Nelson S Yee
Journal:  J Clin Oncol       Date:  2016-05-31       Impact factor: 44.544

Review 3.  Algenpantucel-L immunotherapy in pancreatic adenocarcinoma.

Authors:  Andrew L Coveler; Gabriela R Rossi; Nicholas N Vahanian; Charles Link; E Gabriela Chiorean
Journal:  Immunotherapy       Date:  2016-01-20       Impact factor: 4.196

4.  Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis.

Authors:  Quisette P Janssen; Stefan Buettner; Mustafa Suker; Berend R Beumer; Pietro Addeo; Philippe Bachellier; Nathan Bahary; Tanios Bekaii-Saab; Maria A Bali; Marc G Besselink; Brian A Boone; Ian Chau; Stephen Clarke; Mary Dillhoff; Bassel F El-Rayes; Jessica M Frakes; Derek Grose; Peter J Hosein; Nigel B Jamieson; Ammar A Javed; Khurum Khan; Kyu-Pyo Kim; Song Cheol Kim; Sunhee S Kim; Andrew H Ko; Jill Lacy; Georgios A Margonis; Martin D McCarter; Colin J McKay; Eric A Mellon; Sing Yu Moorcraft; Ken-Ichi Okada; Alessandro Paniccia; Parag J Parikh; Niek A Peters; Hans Rabl; Jaswinder Samra; Christoph Tinchon; Geertjan van Tienhoven; Eran van Veldhuisen; Andrea Wang-Gillam; Matthew J Weiss; Johanna W Wilmink; Hiroki Yamaue; Marjolein Y V Homs; Casper H J van Eijck; Matthew H G Katz; Bas Groot Koerkamp
Journal:  J Natl Cancer Inst       Date:  2019-08-01       Impact factor: 13.506

5.  Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Margaret A Tempero; Mokenge P Malafa; Mahmoud Al-Hawary; Stephen W Behrman; Al B Benson; Dana B Cardin; E Gabriela Chiorean; Vincent Chung; Brian Czito; Marco Del Chiaro; Mary Dillhoff; Timothy R Donahue; Efrat Dotan; Cristina R Ferrone; Christos Fountzilas; Jeffrey Hardacre; William G Hawkins; Kelsey Klute; Andrew H Ko; John W Kunstman; Noelle LoConte; Andrew M Lowy; Cassadie Moravek; Eric K Nakakura; Amol K Narang; Jorge Obando; Patricio M Polanco; Sushanth Reddy; Marsha Reyngold; Courtney Scaife; Jeanne Shen; Charles Vollmer; Robert A Wolff; Brian M Wolpin; Beth Lynn; Giby V George
Journal:  J Natl Compr Canc Netw       Date:  2021-04-01       Impact factor: 11.908

6.  Neoadjuvant Therapy Remodels the Pancreatic Cancer Microenvironment via Depletion of Protumorigenic Immune Cells.

Authors:  Carmen Mota Reyes; Steffen Teller; Alexander Muckenhuber; Björn Konukiewitz; Okan Safak; Wilko Weichert; Helmut Friess; Güralp O Ceyhan; Ihsan Ekin Demir
Journal:  Clin Cancer Res       Date:  2019-10-04       Impact factor: 12.531

7.  A Phase 3 Randomized Clinical Trial of Chemotherapy With or Without Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy in Subjects With Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer.

Authors:  Daniel Brock Hewitt; Nicholas Nissen; Hassan Hatoum; Benjamin Musher; John Seng; Andrew L Coveler; Raed Al-Rajabi; Charles J Yeo; Benjamin Leiby; Joshua Banks; Lodovico Balducci; Gina Vaccaro; Noelle LoConte; Thomas J George; Warren Brenner; Emad Elquza; Nicholas Vahanian; Gabriela Rossi; Eugene Kennedy; Charles Link; Harish Lavu
Journal:  Ann Surg       Date:  2022-01-01       Impact factor: 12.969

Review 8.  Turning the corner on therapeutic cancer vaccines.

Authors:  Robert E Hollingsworth; Kathrin Jansen
Journal:  NPJ Vaccines       Date:  2019-02-08       Impact factor: 7.344

9.  Gemcitabine/Nab-Paclitaxel versus FOLFIRINOX in Locally Advanced Pancreatic Cancer: A European Multicenter Study.

Authors:  Nicolas Williet; Angelica Petrillo; Gaël Roth; Michele Ghidini; Mila Petrova; Julien Forestier; Anthony Lopez; Audrey Thoor; Lucie Weislinger; Ferdinando De Vita; Julien Taieb; Jean Marc Phelip
Journal:  Cancers (Basel)       Date:  2021-06-04       Impact factor: 6.639
View more
  1 in total

Review 1.  Nanoparticle-based immunotherapy of pancreatic cancer.

Authors:  Gaetan Aime Noubissi Nzeteu; Bernhard F Gibbs; Nika Kotnik; Achim Troja; Maximilian Bockhorn; N Helge Meyer
Journal:  Front Mol Biosci       Date:  2022-08-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.